Active ingredientResiquimodCat. No. P-R039-001CAS 144875-48-9Family · Pharmaceutical analytical standards
Resiquimod
An immune response modifier of the imidazoquinoline family that activates Toll-like receptors 7 and 8: in the first two decades of the 21st century it was studied as a gel against genital herpes, actinic keratosis and cutaneous T-cell lymphoma, and as a vaccine adjuvant. This family brings together the active ingredient and labelled standards.
Did you know?In 2002 it was discovered that in humans it acts through two distinct receptors, TLR7 and TLR8: either one alone is enough to make cells responsive to the molecule.
Go to the active ingredient →Active ingredientResiquimodCat. No. P-R039-001CAS 144875-48-9
Isotopically labelledResiquimod-d5Cat. No. P-R039-002CAS 2252319-44-9No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.